NCT03606668

Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR methods and collect preliminary data in order to support research grants and inform larger clinical trials. Additionally, this proposed study will explore the tolerability and preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can acutely reduce the severity of symptom burden caused by neurological disorders.

Conditions

• Multiple Sclerosis
• Chronic Pain
• Neurological Disorder

Interventions

Type	Name	Description
DEVICE	HTC Vive Virtual Reality (VR) system	VR treatment will entail use of computer software designed to immerse participants and engage them in exercises. Software includes virtual painting, walking through vivid and calming settings, solving puzzles, among others.

Timeline

• Start date: 2018-06-20
• Primary completion: 2020-03-02
• Completion: 2020-03-02
• First posted: 2018-07-31
• Last updated: 2022-02-11
• Results posted: 2022-02-11

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study